CYPROMED AS

2312 OTTESTAD

Finances

Share Ownership

Return on Equity

58,93 %

Current Ratio

1,54

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	35 976 000	33 509 000	28 456 000	18 978 000
Net Income	4 636 000	4 966 000	4 446 000	910 000
Total Assets	21 045 000	18 142 000	15 560 000	10 639 000
Total Equity	7 867 000	7 231 000	5 065 000	3 419 000

Income (NOK)	2022	2021	2020	2019
Revenue	35 976 000	33 509 000	28 456 000	18 978 000
Expenditure	30 050 000	26 943 000	22 578 000	17 851 000
Operating Profit	5 926 000	6 566 000	5 879 000	1 128 000
Financial Income	59 000	56 000	90 000	45 000
Financial Costs	56 000	60 000	76 000	60 000
Financial Balance	3 000	−4 000	14 000	−15 000
Earnings Before Tax	5 929 000	6 561 000	5 894 000	1 114 000
Tax	1 292 000	1 595 000	1 448 000	204 000
Net Income	4 636 000	4 966 000	4 446 000	910 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	738 000	975 000	412 000	355 000
Total Current Assets	20 307 000	17 166 000	15 147 000	10 284 000
Total Assets	21 045 000	18 142 000	15 560 000	10 639 000
Total Retained Equity	7 059 000	6 422 000	4 256 000	2 610 000
Total Equity	7 867 000	7 231 000	5 065 000	3 419 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	13 178 000	10 911 000	10 495 000	7 220 000
Total Equity and Debt	21 045 000	18 142 000	15 560 000	10 639 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	35 914 000	32 907 000	28 456 000	18 906 000
Other Income	62 000	602 000	0	72 000
Revenue	35 976 000	33 509 000	28 456 000	18 978 000
Cost of Goods Sold	13 008 000	11 958 000	9 575 000	7 247 000
Salary Costs	13 383 000	11 307 000	9 245 000	7 158 000
Depreciation	311 000	206 000	133 000	154 000
Impairment	0	0	0	0
Expenditure	30 050 000	26 943 000	22 578 000	17 851 000
Operating Profit	5 926 000	6 566 000	5 879 000	1 128 000
Financial Income	59 000	56 000	90 000	45 000
Financial Costs	56 000	60 000	76 000	60 000
Financial Balance	3 000	−4 000	14 000	−15 000
Dividends	4 000 000	2 800 000	2 800 000	0
Net Income	4 636 000	4 966 000	4 446 000	910 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	391 000	568 000	91 000	0
Fixtures	348 000	407 000	321 000	355 000
Total Tangible Assets	738 000	975 000	412 000	355 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	738 000	975 000	412 000	355 000
Stock	5 712 000	3 572 000	5 407 000	2 268 000
Total Investments	0	0	0	0
Cash, Bank	9 487 000	11 397 000	5 852 000	4 791 000
Total Current Assets	20 307 000	17 166 000	15 147 000	10 284 000
Total Assets	21 045 000	18 142 000	15 560 000	10 639 000
Total Equity	7 867 000	7 231 000	5 065 000	3 419 000
Short-Term Group Debt	0	0	0	1 500 000
Total Long-Term Debt	0	0	0	0
Creditors	3 391 000	2 217 000	1 317 000	2 190 000
Unpaid Taxes	1 256 000	1 266 000	1 923 000	1 210 000
Dividends	4 000 000	2 800 000	2 800 000	0
Other Current Debt	3 238 000	3 032 000	3 007 000	2 117 000
Total Current Debt	13 178 000	10 911 000	10 495 000	7 220 000
Total Equity and Debt	21 045 000	18 142 000	15 560 000	10 639 000

Financial indicators	2022	2021	2020	2019
Return on Equity	58,93 %	68,68 %	87,78 %	26,62 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	16,47 %	19,59 %	20,66 %	5,94 %
Current Ratio	1,54	1,57	1,44	1,42
Quick Ratio	2,72	2,34	2,98	2,08
Equity Ratio	0,37	0,4	0,33	0,32
Gross Profit Margin	63,84 %	64,31 %	66,35 %	61,81 %